IL6 and systemic sclerosis: Our group confirmed a significant increase in IL-6 expression in lung tissues derived from SSc patients compared with healthy lung tissues [10] and showed that the increase in lung fibroblasts is mechanistically driven, at least in part, by upregulated lysyl oxidase (LOX) via activation of c-Fos [71].